1 Jee AS, Corte TJ. Current and emerging drug therapies for connective tissue disease-interstitial lung disease(CTD-ILD)[J]. Drugs(New York, N.Y.), 2019, 79(14): 1511-1528.
2 Kondoh Y, Makino S, Ogura T, et al. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease[J]. Respiratory Investigation, 2021, 59(6): 709-740.
3 Koo SM, Kim SY, Choi SM, et al. Korean guidelines for diagnosis and management of interstitial lung diseases: Part 5. Connective tissue disease associated interstitial lung disease[J]. Tuberc Respir Dis(Seoul), 2019, 82(4): 285-297.
4 Jee AS, Sheehy R, Hopkins P, et al. Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the thoracic society of Australia and New Zealand[J]. Respirology, 2021, 26(1): 23-51.
5 Oldroyd AGS, Lilleker JB, Amin T, et al. British society for rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy[J]. Rheumatology(Oxford, England), 2022, 61(5): 1760-1768.
6 Cottin V, Bonniaud P, Cadranel J, et al. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis-2021 update. Full-length version[J]. Res Med Res, 2023, 83: 100948.
7 中华医学会呼吸病学分会, 中国医师协会呼吸医师分会. 间质性肺疾病多学科讨论规范中国专家共识 [J]. 中华结核和呼吸杂志, 2023, 46(12): 1176-1188.
8 宋定云, 张 曙, 张丽萍, 等. 不同类型特发性间质性肺炎患者小气道病变的差异[J]. 中华医学杂志, 2019, 99(30): 2325-2331.
9 Travis WD, Costabel U, Hansell DM, et al. An official american thoracic society/european respiratory society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias[J]. Am J Respir Crit Care Med, 2013, 188(6): 733-748.
10 Aletaha D, Neogi T, Silman A J, et al. 2010 Rheumatoid arthritis classification criteria: an american college of rheumatology/european league against rheumatism collaborative initiative[J]. Arthritis Rheum, 2010, 62(9): 2569-2581.
11 van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative[J]. Ann Rheum Dis, 2013, 72(11): 1747-1755.
12 Aringer M, Costenbader K, Daikh D, et al. 2019 European league against rheumatism/american College of Rheumatology classification criteria for systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(9): 1151-1159.
13 Oldroyd A, Lilleker JB, Amin T, et al. British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy[J]. Rheumatology(Oxford), 2022, 61(5): 1760-1768.
14 Jian W, Gao Y, Hao C, et al. Reference values for spirometry in Chinese aged 4-80 years[J]. J Thoracic Disease, 2017, 9(11): 4538-4549.
15 黄懿洁, 艾 涛. 小气道功能障碍的测定及其临床意义[J]. 中国实用儿科杂志, 2021, 36(6): 420-425.
16 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南(第二部分)——肺量计检查[J]. 中华结核和呼吸杂志, 2014, 37(7): 481-486.
17 王雪晨, 金建敏. 支气管哮喘小气道功能障碍的检测方法及临床应用进展[J]. 中华结核和呼吸杂志, 2023, 46(8): 824-828.
18 Barkas GI, Daniil Z, Kotsiou OS. The role of small airway disease in pulmonary fibrotic diseases[J]. J Pers Med, 2023, 13(11): 1600.
19 卢冬梅, 于碧磬, 杨晓红. 原发性干燥综合征并间质性肺疾病临床分析[J]. 新疆医科大学学报, 2015, 38(8): 984-987.
20 Xu L, Sgalla G, Wang F, et al. Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study[J]. BMC Pulmon Med, 2023, 23(1): 90.
21 Panagopoulos PK, Goules AV, Georgakopoulou VE, et al. Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease[J]. Front Med(Lausanne), 2022, 9: 1016898.
22 Andrade FM, Oliveira AD, Lopes AJ. Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension[J]. Braz J Med Biol Res, 2019, 52(8): e8513.
23 Bonifazi M, Sverzellati N, Negri E, et al. Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry[J]. Rheumatology(Oxford), 2020, 59(3): 641-649.
24 Distler O, Assassi S, Cottin V, et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease[J]. Eur Respir J, 2020, 55(5): 1902026.
25 Grosicka A, Manasar A, Kucharz EJ, et al. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity[J]. Best Pract Res Clin Rheumatol, 2018, 32(4): 541-549.
26 Varma S, Yun JH, Kim JS, et al. Clinical characteristics associated with small airways disease in systemic sclerosis[J]. J Scleroderma Relat Disord, 2022, 7(2): 128-134.
27 Ozmen M, Gumus C, Otman E,et al. Tomographic fibrosis score in the patients with systemic sclerosis-associated interstitial lung disease[J]. Eur J Rheumatol, 2023,10(3): 107-113.
28 Ostojic P, Vujovic M. Prevalence and clinical correlates of small airway obstruction in patients with systemic sclerosis[J]. Clin Rheumatol, 2021, 40(4): 1417-1422.
29 Janardana R, Nair AM, Surin AK,et al. Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease? [J]. Clin Rheumatol, 2019, 38(11): 3179-3187.
30 Lee GM, Carroll MB, Galvin JR, et al. Mosaic attenuation pattern: a guide to analysis with HRCT[J]. Radiol Clin North Am, 2022, 60(6): 963-978.